Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Original versus generic voriconazole for invasive fungal disease in hematologic malignancies
ChiCTR1800019383Phase 4Not yet recruiting
- Sponsor
- Tianjin Medical University General Hospital
- Start
- Oct 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of voriconazole in invasive mycoses (2 arms), sponsored by Tianjin Medical University General Hospital. Primary endpoints: Histopathological examination, Microbiological examination and 12 more. Planned start Oct 2018; status: not yet recruiting.
02
Drugs
voriconazole
03
Conditions
invasive mycoses
Beyond the preview
Go deeper on ChiCTR1800019383.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800019383.